BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 15790420)

  • 1. The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis.
    ter Borg PC; Fekkes D; Vrolijk JM; van Buuren HR
    BMC Gastroenterol; 2005 Mar; 5():11. PubMed ID: 15790420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634].
    ter Borg PC; van Os E; van den Broek WW; Hansen BE; van Buuren HR
    BMC Gastroenterol; 2004 Jul; 4():13. PubMed ID: 15251034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study exploring the role of glucocorticoid receptor variants in primary biliary cirrhosis and primary sclerosing cholangitis.
    ter Borg PC; Hagendorf A; van Buuren HR; Koper JW; Lamberts SW
    Neth J Med; 2004 Oct; 62(9):326-31. PubMed ID: 15635817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholestatic liver diseases and health-related quality of life.
    Younossi ZM; Kiwi ML; Boparai N; Price LL; Guyatt G
    Am J Gastroenterol; 2000 Feb; 95(2):497-502. PubMed ID: 10685757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease.
    Silveira MG; Mendes FD; Diehl NN; Enders FT; Lindor KD
    Liver Int; 2009 Aug; 29(7):1094-100. PubMed ID: 19291181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Helicobacter spp. in the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis.
    Boomkens SY; de Rave S; Pot RG; Egberink HF; Penning LC; Rothuizen J; Zondervan PE; Kusters JG
    FEMS Immunol Med Microbiol; 2005 May; 44(2):221-5. PubMed ID: 15866219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence.
    Newton JL; Gibson GJ; Tomlinson M; Wilton K; Jones D
    Hepatology; 2006 Jul; 44(1):91-8. PubMed ID: 16800007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?
    Bressler B; Pinto R; El-Ashry D; Heathcote EJ
    Gut; 2005 Mar; 54(3):407-10. PubMed ID: 15710991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced plasma dehydroepiandrosterone sulfate levels are significantly correlated with fatigue severity in patients with primary biliary cirrhosis.
    Ahboucha S; Pomier-Layrargues G; Vincent C; Hassoun Z; Tamaz R; Baker G; Butterworth RF
    Neurochem Int; 2008; 52(4-5):569-74. PubMed ID: 17669554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis.
    Jones DE; Newton JL
    Aliment Pharmacol Ther; 2007 Feb; 25(4):471-6. PubMed ID: 17270003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced heart rate variability and baroreflex sensitivity in primary biliary cirrhosis.
    Newton JL; Allen J; Kerr S; Jones DE
    Liver Int; 2006 Mar; 26(2):197-202. PubMed ID: 16448458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
    Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
    Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroactive steroids and fatigue severity in patients with primary biliary cirrhosis and hepatitis C.
    Ahboucha S; Butterworth RF; Pomier-Layrargues G; Vincent C; Hassoun Z; Baker GB
    Neurogastroenterol Motil; 2008 Jun; 20(6):671-9. PubMed ID: 18282171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue in patients with primary sclerosing cholangitis.
    Björnsson E; Simren M; Olsson R; Chapman RW
    Scand J Gastroenterol; 2004 Oct; 39(10):961-8. PubMed ID: 15513335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis.
    Mendes FD; Jorgensen R; Keach J; Katzmann JA; Smyrk T; Donlinger J; Chari S; Lindor KD
    Am J Gastroenterol; 2006 Sep; 101(9):2070-5. PubMed ID: 16879434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in patients with primary biliary cirrhosis.
    Poupon RE; Chrétien Y; Chazouillères O; Poupon R; Chwalow J
    Hepatology; 2004 Aug; 40(2):489-94. PubMed ID: 15368455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis.
    Bedlow AJ; Donaldson PT; McFarlane BM; Lombard M; McFarlane IG; Williams R
    J Clin Lab Immunol; 1989 Nov; 30(3):103-9. PubMed ID: 2642168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis.
    Huet PM; Deslauriers J; Tran A; Faucher C; Charbonneau J
    Am J Gastroenterol; 2000 Mar; 95(3):760-7. PubMed ID: 10710071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC.
    Maheshwari A; Yoo HY; Thuluvath PJ
    Am J Gastroenterol; 2004 Mar; 99(3):538-42. PubMed ID: 15056099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure.
    Newton JL; Bhala N; Burt J; Jones DE
    J Hepatol; 2006 Apr; 44(4):776-83. PubMed ID: 16487619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.